Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients
| Image |  |
|---|---|
| Description | scientific article published on 05 August 2021 |
| Author/s |
author: Jeroen Schouten Matthijs Kox Tim Frenzel Emma J Kooistra Peter Pickkers |
| Publication date | August 5, 2021 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |